In LUAD, some study has shown that the frequency of CDKN2A mutations is higher in lung carcinoma tissues than in tumor-adjacent normal tissues, indicating that CDKN2A mutations can be associated with tumorigenesis (44). The gene discussed is CDKN2A; the disease is neoplasm.